Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema (unspecified eye)
ICD-10 E10.3519 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema (unspecified eye).
E10.3519 refers to a specific complication of Type 1 diabetes mellitus characterized by proliferative diabetic retinopathy (PDR) accompanied by macular edema in an unspecified eye. PDR is a severe form of diabetic retinopathy where new, abnormal blood vessels grow on the retina, which can lead to vision loss. Macular edema occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. This condition is often a result of chronic hyperglycemia, which can lead to damage of the retinal blood vessels. Patients with Type 1 diabetes typically require insulin therapy to manage their blood glucose levels effectively. Regular monitoring of HbA1c levels is crucial, as elevated levels indicate poor glycemic control, increasing the risk of diabetic complications such as retinopathy. The management of this condition often involves a multidisciplinary approach, including endocrinologists, ophthalmologists, and diabetes educators, to optimize blood sugar control and monitor for ocular complications.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications.
Ensure comprehensive documentation of diabetes management and any referrals to ophthalmology.
Thorough eye examination reports detailing the presence and severity of retinopathy and edema.
Patients with vision changes due to diabetic retinopathy.
Document the specific findings of the eye examination and any treatments provided.
Used for routine eye exams in patients with diabetes.
Document the findings of the eye examination and any treatments provided.
Ophthalmologists should ensure detailed documentation of retinopathy findings.
Coding E10.3519 accurately reflects the severity of complications associated with Type 1 diabetes, which is crucial for appropriate management and reimbursement.
